Viracta Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Viracta Therapeutics

12/08/2021 15:05

* Viracta Therapeutics Inc  VIRX.OQ  reported a quarterly
adjusted loss of 25 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 24 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Viracta Therapeutics Inc's reported EPS for the quarter was a
loss of 25 cents​.
* The mean earnings estimate of analysts had risen by
about 40.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Viracta Therapeutics Inc shares had fallen by 8.0% this
quarter and gained 49.7% so far this year.
* The company reported a quarterly loss of $9.17 million.
* Wall Street's median 12-month price target for Viracta
Therapeutics Inc is $35.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 02:05 p.m.  ​All
figures in US dollars unless otherwise stated